The 9th GPPAD Investigator Meeting took place June 8 and 9, 2021.

Type 1 diabetes is the most common metabolic disease in children and adolescents worldwide. It can be particularly dangerous as often there is no diagnosis until severe and sometimes life-threatening symptoms have already developed. The new ‘SINT1A‘ study explores the...

Is it possible to prevent the development of type 1 diabetes in children with an increased risk of type 1 diabetes by adding insulin powder to their diet? This is what we want to find out with our prevention study POInT (Primary Oral Insulin Trial). We have now...